Home / Investors

Micropos Medical in brief

Micropos Medical (publ) is a Swedish medical device company with advanced technology (powered by Artificial Intelligence) for enhanced radiotherapy of cancer, such as hypofractionation and Stereotactic Radio Surgery (SRS) / Stereotactic Body RadioTherapy (SBRT). Raypilot is an electromagnetic positioning system that works with existing linacs (linear accelerators) in order to enable non-ionizing, objective and real-time tumuor tracking in radiation therapy for prostate cancer. The Micropos share is traded under the stock ticker MPOS on the Spotlight Stock Market.

Financial calender for 2022 and 2023

  • 28 February 2022 – Year-end report and interim report Q4 2021
  • 28 April 2022 – interim report Q1 2022
  • 28 July 2022 – interim report Q2 2022
  • 27 October 2022 – interim report Q3 2022
  • 30 January 2023 – interim report Q4 2022

For additional information, please contact:

Thomas Lindström, CEO, Micropos Medical AB (publ)

+46-31-760 80 05, info@micropos.se

Share info

For more information about the share, please visit Spotlight.

News

Micropos årsstämma hölls igår den 24 maj i Göteborg.

Micropos årsstämma hölls igår onsdagen den 24 maj i Göteborg. Vi tackar alla medverkande för en trevlig stämma. Bolagets VD Thomas Lindström säger: –       Vi befinner… Read More

Read more
See all news

Annual Reports

micropos-medical_arsredovisning-2021

Årsredovisning 2021

Download READ HERE

Interim Reports

micropos_q2-rapport_2022

Micropos Q2 2022

Download

Follow us on LinkedIn

Visit our LinkedIn page